Recent Finacing
Recent Raise
Sciwind Biosciences is a clinical-stage biopharmaceutical company developing GLP-1 receptor agonist therapies using oral peptide and inhaled protein delivery platforms, advancing XW003, XW004, and XW014 for metabolic diseases.
